Nasdaq · CIK 0001819576
LQDA Liquidia Corp
Insider trading from SEC Form 4. Last filing 5 d ago. Close $27.38 on Oct 9, 2026, +24% from the 52-week low and -70% from the high.
Last 90 days
Net insider value
-$7.6M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
3
$7.6M by 3 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
LQDAOct 9, 2026 · close 27.38
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Liquidia Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Stephen M Bloch director sell | $6.4M 235,477 shares | -100% | +26% from low-70% from high | |
| 43Moderate | Raman Singh director sell | $1.2M 17,492 shares | -33% | +206% from low-27% from high | |
| 3Weak | Sarah Krepp Chief Human Resource Officer sell | $19k 274 shares | -0% | +207% from low-27% from high | |
| 0Weak | Jason Adair Chief Business Officer sell | $22k 693 shares | -0% | +203% from low-2% from high | |
| 10Weak | Dana Boyle Chief Accounting Officer sell | $9,754 303 shares | -0% | +203% from low-2% from high | |
| 8Weak | Michael Kaseta CFO and COO sell | $38k 1,166 shares | -0% | +203% from low-2% from high | |
| 10Weak | Sarah Krepp Chief Human Resource Officer sell | $7,114 221 shares | -0% | +203% from low-2% from high | |
| 25Weak | Jason Adair Chief Business Officer sell | $1.1M 35,656 shares | -17% | +208% from low0% from high | |
| 49Moderate | Dana Boyle Chief Accounting Officer sell | $728k 29,004 shares | -16% | +166% from low-11% from high | |
| 10Weak | Jason Adair Chief Business Officer sell | $16k 692 shares | -0% | +132% from low-22% from high | |
| 10Weak | Dana Boyle Chief Accounting Officer sell | $25k 1,073 shares | -1% | +132% from low-22% from high | |
| 4Weak | Jason Adair Chief Business Officer sell | $86k 3,670 shares | -2% | +142% from low-19% from high | |
| 15Weak | Dana Boyle Chief Accounting Officer sell | $29k 1,238 shares | -1% | +142% from low-19% from high | |
| 22Weak | Roger Jeffs Chief Executive Officer sell | $474k 20,261 shares | -2% | +142% from low-19% from high | |
| 15Weak | Michael Kaseta CFO and COO sell | $272k 11,630 shares | -3% | +142% from low-19% from high | |
| 16Weak | Sarah Krepp Chief Human Resource Officer sell | $40k 1,691 shares | -1% | +142% from low-19% from high | |
| 60Notable | Raman Singh director sell | $1.2M 45,524 shares | -59% | +174% from low-8% from high | |
| 47Moderate | Raman Singh director sell | $221k 7,500 shares | -19% | +201% from low0% from high | |
| 10Weak | Dana Boyle Chief Accounting Officer sell | $8,599 296 shares | -0% | +185% from low-1% from high | |
| 8Weak | Michael Kaseta CFO and COO sell | $33k 1,148 shares | -0% | +194% from low0% from high | |
| 10Weak | Sarah Krepp Chief Human Resource Officer sell | $6,071 209 shares | -0% | +185% from low-1% from high | |
| 0Weak | Russell Schundler General Counsel sell | $31k 1,063 shares | -0% | +194% from low0% from high | |
| 30Weak | Scott Moomaw Chief Commercial Officer sell | $2.0M 70,692 shares | -31% | +194% from low0% from high | |
| 21Weak | Jason Adair Chief Business Officer sell | $739k 26,508 shares | -13% | +183% from low-2% from high | |
| 29Weak | Rajeev Saggar Chief Medical Officer sell | $557k 20,000 shares | -7% | +183% from low-2% from high | |
| 75Notable | Paul B Manning director sell | $19M 670,837 shares | -61% | +183% from low-2% from high | |
| 46Moderate | Joanna Horobin director sell | $136k 5,000 shares | -13% | +179% from low-2% from high | |
| 35Weak | Michael Kaseta CFO and COO sell | $524k 20,000 shares | -5% | +167% from low-1% from high | |
| 36Weak | Michael Kaseta CFO and COO sell | $600k 30,000 shares | -7% | +106% from low0% from high | |
| 10Weak | Jason Adair Chief Business Officer sell | $8,871 454 shares | -0% | +104% from low0% from high | |
| 10Weak | Dana Boyle Chief Accounting Officer sell | $21k 1,063 shares | -1% | +104% from low0% from high | |
| 16Weak | Rajeev Saggar Chief Medical Officer sell | $37k 2,526 shares | -1% | +55% from low-22% from high | |
| 1Weak | Jason Adair Chief Business Officer sell | $37k 2,576 shares | -1% | +49% from low-25% from high | |
| 10Weak | Dana Boyle Chief Accounting Officer sell | $17k 1,193 shares | -1% | +49% from low-25% from high | |
| 19Weak | Roger Jeffs Chief Executive Officer sell | $289k 20,252 shares | -2% | +49% from low-25% from high | |
| 19Weak | Roger Jeffs Chief Executive Officer sell | $289k 20,252 shares | -2% | +49% from low-25% from high | |
| 13Weak | Michael Kaseta CFO and COO sell | $165k 11,580 shares | -3% | +49% from low-25% from high | |
| 16Weak | Sarah Krepp Chief Human Resource Officer sell | $38k 2,673 shares | -2% | +49% from low-25% from high | |
| 3Weak | Scott Moomaw Chief Commercial Officer sell | $69k 4,797 shares | -2% | +49% from low-25% from high | |
| 3Weak | Rajeev Saggar Chief Medical Officer sell | $76k 5,327 shares | -2% | +49% from low-25% from high | |
| 5Weak | Russell Schundler General Counsel sell | $112k 7,836 shares | -1% | +49% from low-25% from high | |
| 2Weak | Jason Adair Chief Business Officer sell | $61k 3,597 shares | -2% | +81% from low-9% from high | |
| 23Weak | Roger Jeffs Chief Executive Officer sell | $519k 30,610 shares | -3% | +81% from low-9% from high | |
| 15Weak | Michael Kaseta CFO and COO sell | $251k 14,777 shares | -3% | +81% from low-9% from high | |
| 5Weak | Scott Moomaw Chief Commercial Officer sell | $113k 6,656 shares | -3% | +81% from low-9% from high | |
| 6Weak | Rajeev Saggar Chief Medical Officer sell | $129k 7,597 shares | -3% | +81% from low-9% from high | |
| 6Weak | Russell Schundler General Counsel sell | $144k 8,460 shares | -1% | +81% from low-9% from high | |
| 0Weak | Jason Adair Chief Business Officer sell | $7,550 451 shares | -0% | +74% from low-13% from high | |
| 2Weak | Michael Kaseta CFO and COO sell | $14k 859 shares | -0% | +74% from low-13% from high | |
| 0Weak | Scott Moomaw Chief Commercial Officer sell | $9,726 581 shares | -0% | +74% from low-13% from high | |
| 0Weak | Russell Schundler General Counsel sell | $15k 923 shares | -0% | +74% from low-13% from high | |
| 10Weak | Jason Adair Chief Business Officer sell | $6,479 455 shares | -0% | +46% from low-14% from high | |
| 16Weak | Rajeev Saggar Chief Medical Officer sell | $33k 2,450 shares | -1% | +37% from low-20% from high | |
| 32Weak | Roger Jeffs Chief Executive Officer sell | $192k 14,130 shares | -1% | +42% from low-16% from high | |
| 27Weak | Michael Kaseta CFO and COO sell | $112k 8,283 shares | -2% | +42% from low-16% from high | |
| 17Weak | Rajeev Saggar Chief Medical Officer sell | $50k 3,714 shares | -1% | +42% from low-16% from high | |
| 16Weak | Scott Moomaw Chief Commercial Officer sell | $46k 3,406 shares | -2% | +40% from low-18% from high | |
| 19Weak | Russell Schundler General Counsel sell | $81k 5,964 shares | -1% | +42% from low-16% from high | |
| 0Weak | Jason Adair Chief Business Officer sell | $25k 1,856 shares | -1% | +42% from low-16% from high | |
| 0Weak | Jason Adair Chief Business Officer sell | $6,968 451 shares | -0% | +53% from low-10% from high | |
| 0Weak | Michael Kaseta CFO and COO sell | $14k 874 shares | -0% | +53% from low-10% from high | |
| 10Weak | Jason Adair Chief Business Officer sell | $6,319 445 shares | -0% | +44% from low-3% from high | |
| 2Weak | Jason Adair Chief Business Officer sell | $57k 4,809 shares | -3% | +17% from low-9% from high | |
| 33Weak | Roger Jeffs Chief Executive Officer sell | $263k 22,343 shares | -2% | +17% from low-9% from high | |
| 31Weak | Michael Kaseta CFO and COO sell | $275k 23,370 shares | -5% | +17% from low-9% from high | |
| 0Weak | Jason Adair Chief Business Officer sell | $5,237 455 shares | -0% | - | |
| 2Weak | Michael Kaseta CFO and COO sell | $13k 1,091 shares | -0% | - | |
| 0Weak | Russell Schundler General Counsel sell | $12k 1,063 shares | -0% | - | |
| 0Weak | Scott Moomaw Chief Commercial Officer sell | $6,284 546 shares | -0% | - | |
| 10Weak | Jason Adair Chief Business Officer sell | $5,190 459 shares | -0% | +13% from low-5% from high | |
| 10Weak | Jason Adair Chief Business Officer sell | $5,190 459 shares | -0% | +13% from low-5% from high | |
| 15Weak | Rajeev Saggar Chief Medical Officer sell | $28k 2,526 shares | -1% | +15% from low-4% from high | |
| 0Weak | Jason Adair Chief Business Officer sell | $13k 1,146 shares | -1% | +15% from low-0% from high | |
| 29Weak | Roger Jeffs Chief Executive Officer sell | $89k 8,053 shares | -1% | +15% from low-0% from high | |
| 23Weak | Michael Kaseta CFO and COO sell | $43k 3,892 shares | -1% | +15% from low-0% from high | |
| 10Weak | Scott Moomaw Chief Commercial Officer sell | $17k 1,527 shares | -1% | +15% from low-0% from high | |
| 15Weak | Rajeev Saggar Chief Medical Officer sell | $25k 2,260 shares | -1% | +15% from low-0% from high | |
| 15Weak | Russell Schundler General Counsel sell | $29k 2,576 shares | -1% | +15% from low-0% from high |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Stephen M Bloch director | SOpen-market sale Common Stockindirect: See footnote | -235,477 | $27.13 | $6.4M | 0 | 5 d ago |
| Sep 11, 2026 | Raman Singh director | MOption exercise Common Stock | +556 | $8.63 | $4,798 | 45,193 | 27 d ago |
| Sep 11, 2026 | Raman Singh director | MOption exercise Common Stock | +8,468 | $9.31 | $79k | 53,661 | 27 d ago |
| Sep 11, 2026 | Raman Singh director | SOpen-market sale Common Stock | -9,024 | $68.62 | $619k | 44,637 | 27 d ago |
| Sep 14, 2026 | Raman Singh director | MOption exercise Common Stock | +8,468 | $9.31 | $79k | 53,105 | 27 d ago |
| Sep 14, 2026 | Raman Singh director | SOpen-market sale Common Stock | -8,468 | $66.16 | $560k | 44,637 | 27 d ago |
| Sep 11, 2026 | Raman Singh director | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -556 | $0.00 | $0 | 0 | 27 d ago |
| Sep 11, 2026 | Raman Singh director | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -8,468 | $0.00 | $0 | 8,468 | 27 d ago |
| Sep 14, 2026 | Raman Singh director | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -8,468 | $0.00 | $0 | 0 | 27 d ago |
| Sep 1, 2026 | Sarah Krepp Chief Human Resource Officer | SOpen-market sale Common Stock10b5-1 | -274 | $67.76 | $19k | 117,308 | 39 d ago |
| Nov 28, 2025 | Michael Kaseta CFO and COO | MOption exercise Common Stock10b5-1 | +2,343 | - | - | 354,989 | Dec 2, 2025 |
| Nov 28, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +1,563 | - | - | 176,561 | Dec 2, 2025 |
| Dec 1, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -303 | $32.19 | $9,754 | 155,031 | Dec 2, 2025 |
| Dec 1, 2025 | Sarah Krepp Chief Human Resource Officer | SOpen-market sale Common Stock10b5-1 | -221 | $32.19 | $7,114 | 141,218 | Dec 2, 2025 |
| Dec 1, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -693 | $32.19 | $22k | 175,868 | Dec 2, 2025 |
| Dec 1, 2025 | Michael Kaseta CFO and COO | SOpen-market sale Common Stock10b5-1 | -1,166 | $32.19 | $38k | 353,823 | Dec 2, 2025 |
| Nov 28, 2025 | Michael Kaseta CFO and COO | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,343 | $0.00 | $0 | 2,344 | Dec 2, 2025 |
| Nov 28, 2025 | Jason Adair Chief Business Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,563 | $0.00 | $0 | 1,562 | Dec 2, 2025 |
| Nov 18, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +35,291 | $5.89 | $208k | 210,289 | Nov 20, 2025 |
| Nov 18, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +365 | $5.89 | $2,150 | 210,654 | Nov 20, 2025 |
| Nov 18, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -35,656 | $30.03 | $1.1M | 174,998 | Nov 20, 2025 |
| Nov 18, 2025 | Jason Adair Chief Business Officer | MOption exercise Incentive Stock Option (right to buy)derivative10b5-1 | -35,291 | $0.00 | $0 | 0 | Nov 20, 2025 |
| Nov 18, 2025 | Jason Adair Chief Business Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -365 | $0.00 | $0 | 0 | Nov 20, 2025 |
| Nov 7, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock | -8,342 | $25.16 | $210k | 175,996 | Nov 12, 2025 |
| Nov 7, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock | -20,662 | $25.06 | $518k | 155,334 | Nov 12, 2025 |
| Oct 27, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -692 | $22.93 | $16k | 174,998 | Oct 29, 2025 |
| Oct 27, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -1,073 | $22.93 | $25k | 184,338 | Oct 29, 2025 |
| Oct 10, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +3,906 | - | - | 176,886 | Oct 15, 2025 |
| Oct 13, 2025 | Sarah Krepp Chief Human Resource Officer | SOpen-market sale Common Stock10b5-1 | -1,691 | $23.41 | $40k | 141,439 | Oct 15, 2025 |
| Oct 10, 2025 | Roger Jeffs Chief Executive Officer | MOption exercise Common Stock10b5-1 | +13,834 | - | - | 1,053,234 | Oct 15, 2025 |
| Oct 10, 2025 | Michael Kaseta CFO and COO | MOption exercise Common Stock10b5-1 | +5,828 | - | - | 364,276 | Oct 15, 2025 |
| Oct 13, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -1,238 | $23.41 | $29k | 185,411 | Oct 15, 2025 |
| Oct 10, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +2,474 | - | - | 179,360 | Oct 15, 2025 |
| Oct 13, 2025 | Roger Jeffs Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -20,261 | $23.41 | $474k | 1,032,973 | Oct 15, 2025 |
| Oct 13, 2025 | Michael Kaseta CFO and COO | SOpen-market sale Common Stock10b5-1 | -11,630 | $23.41 | $272k | 352,646 | Oct 15, 2025 |
| Oct 10, 2025 | Michael Kaseta CFO and COO | MOption exercise Performance Stock Unitderivative10b5-1 | -5,828 | $0.00 | $0 | 52,453 | Oct 15, 2025 |
| Oct 13, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -3,670 | $23.41 | $86k | 175,690 | Oct 15, 2025 |
| Oct 10, 2025 | Jason Adair Chief Business Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -3,906 | $0.00 | $0 | 19,531 | Oct 15, 2025 |
| Oct 10, 2025 | Jason Adair Chief Business Officer | MOption exercise Performance Stock Unitderivative10b5-1 | -2,474 | $0.00 | $0 | 22,268 | Oct 15, 2025 |
| Oct 10, 2025 | Roger Jeffs Chief Executive Officer | MOption exercise Performance Stock Unitsderivative10b5-1 | -13,834 | $0.00 | $0 | 124,502 | Oct 15, 2025 |
| Sep 15, 2025 | Raman Singh director | MOption exercise Common Stock | +25,524 | $2.51 | $64k | 56,779 | Sep 17, 2025 |
| Sep 15, 2025 | Raman Singh director | MOption exercise Common Stock | +20,000 | $2.59 | $52k | 76,779 | Sep 17, 2025 |
| Sep 15, 2025 | Raman Singh director | SOpen-market sale Common Stock | -45,524 | $25.81 | $1.2M | 31,255 | Sep 17, 2025 |
| Sep 15, 2025 | Raman Singh director | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -25,524 | $0.00 | $0 | 0 | Sep 17, 2025 |
| Sep 15, 2025 | Raman Singh director | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -20,000 | $0.00 | $0 | 0 | Sep 17, 2025 |
| Sep 3, 2025 | Raman Singh director | SOpen-market sale Common Stock | -7,500 | $29.42 | $221k | 31,255 | Sep 5, 2025 |
| Aug 29, 2025 | Scott Moomaw Chief Commercial Officer | MOption exercise Common Stock10b5-1 | +1,875 | - | - | 225,946 | Sep 3, 2025 |
| Aug 29, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -296 | $29.05 | $8,599 | 186,649 | Sep 3, 2025 |
| Aug 29, 2025 | Michael Kaseta CFO and COO | MOption exercise Common Stock10b5-1 | +2,344 | - | - | 359,596 | Sep 3, 2025 |
| Aug 29, 2025 | Sarah Krepp Chief Human Resource Officer | SOpen-market sale Common Stock10b5-1 | -209 | $29.05 | $6,071 | 143,130 | Sep 3, 2025 |
| Aug 29, 2025 | Russell Schundler General Counsel | MOption exercise Common Stock10b5-1 | +2,344 | - | - | 581,161 | Sep 3, 2025 |
| Sep 2, 2025 | Michael Kaseta CFO and COO | SOpen-market sale Common Stock10b5-1 | -1,148 | $29.05 | $33k | 358,448 | Sep 3, 2025 |
| Sep 2, 2025 | Russell Schundler General Counsel | SOpen-market sale Common Stock10b5-1 | -1,063 | $29.05 | $31k | 580,098 | Sep 3, 2025 |
| Sep 2, 2025 | Scott Moomaw Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -692 | $29.05 | $20k | 225,254 | Sep 3, 2025 |
| Sep 2, 2025 | Scott Moomaw Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -8,315 | $28.62 | $238k | 216,939 | Sep 3, 2025 |
| Aug 31, 2025 | Michael Kaseta CFO and COO | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,344 | $0.00 | $0 | 4,687 | Sep 3, 2025 |
| Sep 2, 2025 | Scott Moomaw Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -61,685 | $28.62 | $1.8M | 155,254 | Sep 3, 2025 |
| Aug 29, 2025 | Russell Schundler General Counsel | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,344 | $0.00 | $0 | 4,687 | Sep 3, 2025 |
| Aug 29, 2025 | Scott Moomaw Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,875 | $0.00 | $0 | 3,750 | Sep 3, 2025 |
| Aug 28, 2025 | Rajeev Saggar Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -20,000 | $27.85 | $557k | 249,727 | Sep 2, 2025 |
| Aug 28, 2025 | Paul B Manning director | SOpen-market sale Common Stockindirect: See footnote | -154,337 | $27.94 | $4.3M | 947,328 | Sep 2, 2025 |
| Jul 11, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +3,906 | - | - | 197,086 | Sep 2, 2025 |
| Aug 28, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -26,057 | $27.86 | $726k | 171,029 | Sep 2, 2025 |
| Aug 29, 2025 | Paul B Manning director | SOpen-market sale Common Stockindirect: See footnote | -188,232 | $27.62 | $5.2M | 759,096 | Sep 2, 2025 |
| Sep 2, 2025 | Paul B Manning director | SOpen-market sale Common Stockindirect: See footnote | -254,038 | $28.67 | $7.3M | 505,058 | Sep 2, 2025 |
| Aug 29, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +1,562 | - | - | 173,431 | Sep 2, 2025 |
| Sep 2, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -451 | $29.05 | $13k | 172,980 | Sep 2, 2025 |
| Sep 2, 2025 | Paul B Manning director | SOpen-market sale Common Stockindirect: See footnote | -74,230 | $29.14 | $2.2M | 430,828 | Sep 2, 2025 |
| Jul 11, 2025 | Jason Adair Chief Business Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -3,906 | $0.00 | $0 | 23,438 | Sep 2, 2025 |
| Aug 29, 2025 | Jason Adair Chief Business Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,562 | $0.00 | $0 | 3,125 | Sep 2, 2025 |
| Aug 19, 2025 | Joanna Horobin director | SOpen-market sale Common Stock | -5,000 | $27.17 | $136k | 33,755 | Aug 21, 2025 |
| Aug 15, 2025 | Michael Kaseta CFO and COO | SOpen-market sale Common Stock10b5-1 | -20,000 | $26.18 | $524k | 356,412 | Aug 19, 2025 |
| Aug 5, 2025 | Michael Kaseta CFO and COO | SOpen-market sale Common Stock10b5-1 | -30,000 | $20.00 | $600k | 376,412 | Aug 7, 2025 |
| Jul 28, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -454 | $19.54 | $8,871 | 193,180 | Jul 30, 2025 |
| Jul 28, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -1,063 | $19.54 | $21k | 186,105 | Jul 30, 2025 |
| Jul 21, 2025 | Rajeev Saggar Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -2,526 | $14.54 | $37k | 268,887 | Jul 23, 2025 |
| Jul 14, 2025 | Dana Boyle Chief Accounting Officer | SOpen-market sale Common Stock10b5-1 | -1,193 | $14.28 | $17k | 187,168 | Jul 15, 2025 |
| Jul 14, 2025 | Sarah Krepp Chief Human Resource Officer | SOpen-market sale Common Stock10b5-1 | -2,673 | $14.28 | $38k | 142,499 | Jul 15, 2025 |
| Jul 11, 2025 | Jason Adair Chief Business Officer | MOption exercise Common Stock10b5-1 | +2,475 | - | - | 196,210 | Jul 15, 2025 |
| Jul 11, 2025 | Roger Jeffs Chief Executive Officer | MOption exercise Common Stock10b5-1 | +13,833 | - | - | 1,058,812 | Jul 15, 2025 |
| Jul 11, 2025 | Roger Jeffs Chief Executive Officer | MOption exercise Common Stock10b5-1 | +13,833 | - | - | 1,058,812 | Jul 15, 2025 |
| Jul 11, 2025 | Michael Kaseta CFO and COO | MOption exercise Common Stock10b5-1 | +5,828 | - | - | 417,992 | Jul 15, 2025 |
| Jul 11, 2025 | Scott Moomaw Chief Commercial Officer | MOption exercise Common Stock10b5-1 | +3,107 | - | - | 228,028 | Jul 15, 2025 |
| Jul 11, 2025 | Rajeev Saggar Chief Medical Officer | MOption exercise Common Stock10b5-1 | +3,531 | - | - | 276,740 | Jul 15, 2025 |
| Jul 11, 2025 | Russell Schundler General Counsel | MOption exercise Common Stock10b5-1 | +3,759 | - | - | 585,813 | Jul 15, 2025 |
| Jul 14, 2025 | Jason Adair Chief Business Officer | SOpen-market sale Common Stock10b5-1 | -2,576 | $14.28 | $37k | 193,634 | Jul 15, 2025 |
| Jul 14, 2025 | Roger Jeffs Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -20,252 | $14.28 | $289k | 1,038,560 | Jul 15, 2025 |
| Jul 14, 2025 | Roger Jeffs Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -20,252 | $14.28 | $289k | 1,038,560 | Jul 15, 2025 |
| Jul 14, 2025 | Michael Kaseta CFO and COO | SOpen-market sale Common Stock10b5-1 | -11,580 | $14.28 | $165k | 406,412 | Jul 15, 2025 |
| Jul 14, 2025 | Scott Moomaw Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -4,797 | $14.28 | $69k | 223,231 | Jul 15, 2025 |
| Jul 14, 2025 | Rajeev Saggar Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -5,327 | $14.28 | $76k | 271,413 | Jul 15, 2025 |
| Jul 14, 2025 | Russell Schundler General Counsel | SOpen-market sale Common Stock10b5-1 | -7,836 | $14.28 | $112k | 577,977 | Jul 15, 2025 |
| Jul 11, 2025 | Jason Adair Chief Business Officer | MOption exercise Performance Stock Unitsderivative10b5-1 | -2,475 | $0.00 | $0 | 24,742 | Jul 15, 2025 |
| Jul 11, 2025 | Michael Kaseta CFO and COO | MOption exercise Performance Stock Unitsderivative10b5-1 | -5,828 | $0.00 | $0 | 58,281 | Jul 15, 2025 |
| Jul 11, 2025 | Scott Moomaw Chief Commercial Officer | MOption exercise Performance Stock Unitsderivative10b5-1 | -3,107 | $0.00 | $0 | 31,077 | Jul 15, 2025 |
| Jul 11, 2025 | Rajeev Saggar Chief Medical Officer | MOption exercise Performance Stock Unitsderivative10b5-1 | -3,531 | $0.00 | $0 | 35,307 | Jul 15, 2025 |
| Jul 11, 2025 | Russell Schundler General Counsel | MOption exercise Performance Stock Unitsderivative10b5-1 | -3,759 | $0.00 | $0 | 37,584 | Jul 15, 2025 |
| Jul 11, 2025 | Roger Jeffs Chief Executive Officer | MOption exercise Performance Stock Unitsderivative10b5-1 | -13,833 | $0.00 | $0 | 138,336 | Jul 15, 2025 |
| Jul 11, 2025 | Roger Jeffs Chief Executive Officer | MOption exercise Performance Stock Unitsderivative10b5-1 | -13,833 | $0.00 | $0 | 138,336 | Jul 15, 2025 |
| Jul 1, 2025 | Dana Boyle Chief Accounting Officer | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 188,361 | Jul 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Jason AdairChief Business Officer
- Stephen M Blochdirector
- Dana BoyleChief Accounting Officer
- Joanna Horobindirector
- Roger JeffsChief Executive Officer
- Michael KasetaCFO and COO
- Sarah KreppChief Human Resource Officer
- Paul B Manningdirector, owner
- Scott MoomawChief Commercial Officer
- Raman Singhdirector
- Rajeev SaggarChief Medical Officer
- Russell SchundlerGeneral Counsel
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.